These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 16012954)
1. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Tan X; Apte U; Micsenyi A; Kotsagrelos E; Luo JH; Ranganathan S; Monga DK; Bell A; Michalopoulos GK; Monga SP Gastroenterology; 2005 Jul; 129(1):285-302. PubMed ID: 16012954 [TBL] [Abstract][Full Text] [Related]
2. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355 [TBL] [Abstract][Full Text] [Related]
3. Elevated expression of Wnt antagonists is a common event in hepatoblastomas. Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610 [TBL] [Abstract][Full Text] [Related]
4. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C Cancer Res; 2001 Apr; 61(8):3245-9. PubMed ID: 11309273 [TBL] [Abstract][Full Text] [Related]
5. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Anna CH; Iida M; Sills RC; Devereux TR Toxicol Appl Pharmacol; 2003 Jul; 190(2):135-45. PubMed ID: 12878043 [TBL] [Abstract][Full Text] [Related]
6. Beta-catenin is temporally regulated during normal liver development. Micsenyi A; Tan X; Sneddon T; Luo JH; Michalopoulos GK; Monga SP Gastroenterology; 2004 Apr; 126(4):1134-46. PubMed ID: 15057752 [TBL] [Abstract][Full Text] [Related]
7. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Monga SP; Monga HK; Tan X; Mulé K; Pediaditakis P; Michalopoulos GK Gastroenterology; 2003 Jan; 124(1):202-16. PubMed ID: 12512043 [TBL] [Abstract][Full Text] [Related]
8. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100 [TBL] [Abstract][Full Text] [Related]
9. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. Schroeder JA; Adriance MC; McConnell EJ; Thompson MC; Pockaj B; Gendler SJ J Biol Chem; 2002 Jun; 277(25):22692-8. PubMed ID: 11950845 [TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Apte U; Zeng G; Muller P; Tan X; Micsenyi A; Cieply B; Dai C; Liu Y; Kaestner KH; Monga SP Hepatology; 2006 Oct; 44(4):992-1002. PubMed ID: 17006939 [TBL] [Abstract][Full Text] [Related]
11. Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Calvisi DF; Factor VM; Ladu S; Conner EA; Thorgeirsson SS Gastroenterology; 2004 May; 126(5):1374-86. PubMed ID: 15131798 [TBL] [Abstract][Full Text] [Related]
12. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas. Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519 [TBL] [Abstract][Full Text] [Related]
13. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Cheng JH; She H; Han YP; Wang J; Xiong S; Asahina K; Tsukamoto H Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G39-49. PubMed ID: 18006602 [TBL] [Abstract][Full Text] [Related]
14. Novel role for amphiregulin in protection from liver injury. Berasain C; García-Trevijano ER; Castillo J; Erroba E; Santamaría M; Lee DC; Prieto J; Avila MA J Biol Chem; 2005 May; 280(19):19012-20. PubMed ID: 15753092 [TBL] [Abstract][Full Text] [Related]
15. Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Lyons JP; Mueller UW; Ji H; Everett C; Fang X; Hsieh JC; Barth AM; McCrea PD Exp Cell Res; 2004 Aug; 298(2):369-87. PubMed ID: 15265686 [TBL] [Abstract][Full Text] [Related]
16. A beta-catenin survival signal is required for normal lobular development in the mammary gland. Tepera SB; McCrea PD; Rosen JM J Cell Sci; 2003 Mar; 116(Pt 6):1137-49. PubMed ID: 12584256 [TBL] [Abstract][Full Text] [Related]
17. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade. Calvisi DF; Factor VM; Loi R; Thorgeirsson SS Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770 [TBL] [Abstract][Full Text] [Related]
18. Receptor and secreted targets of Wnt-1/beta-catenin signalling in mouse mammary epithelial cells. Kenny PA; Enver T; Ashworth A BMC Cancer; 2005 Jan; 5():3. PubMed ID: 15642117 [TBL] [Abstract][Full Text] [Related]
19. Wnt-1 but not epidermal growth factor induces beta-catenin/T-cell factor-dependent transcription in esophageal cancer cells. Mizushima T; Nakagawa H; Kamberov YG; Wilder EL; Klein PS; Rustgi AK Cancer Res; 2002 Jan; 62(1):277-82. PubMed ID: 11782388 [TBL] [Abstract][Full Text] [Related]
20. Expression of stabilized beta-catenin in differentiated neurons of transgenic mice does not result in tumor formation. Kratz JE; Stearns D; Huso DL; Slunt HH; Price DL; Borchelt DR; Eberhart CG BMC Cancer; 2002 Dec; 2():33. PubMed ID: 12460454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]